Cargando…

Estimands and Complex Innovative Designs

Since the release of the ICH E9(R1) (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials) document in 2019, the estimand fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collignon, Olivier, Schiel, Anja, Burman, Carl‐Fredrik, Rufibach, Kaspar, Posch, Martin, Bretz, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790227/ https://www.ncbi.nlm.nih.gov/pubmed/35253205 http://dx.doi.org/10.1002/cpt.2575

Ejemplares similares

Estimands—What they are and why they are important for pharmacometricians
por: Akacha, Mouna, et al.
Publicado: (2021)

Understanding estimands
por: Gogtay, Nithya Jaideep, et al.
Publicado: (2021)

What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?
por: Lawrance, Rachael, et al.
Publicado: (2020)

Estimands for factorial trials
por: Kahan, Brennan C., et al.
Publicado: (2022)

Estimands in epigenome-wide association studies
por: Kruppa, Jochen, et al.
Publicado: (2021)

Eliminating Ambiguous Treatment Effects Using Estimands
por: Kahan, Brennan C, et al.
Publicado: (2023)

Estimands to quantify prolonged hospital stay associated with nosocomial infections
por: Wolkewitz, Martin, et al.
Publicado: (2019)

Rethinking intercurrent events in defining estimands for tuberculosis trials
por: Pham, Tra My, et al.
Publicado: (2022)

Some considerations on target estimands for health technology assessment
por: Remiro‐Azócar, Antonio
Publicado: (2022)

Analytical approaches and estimands to take account of missing patient-reported data in longitudinal studies
por: Bell, Melanie L, et al.
Publicado: (2019)

Optimized adaptive enrichment designs
por: Ondra, Thomas, et al.
Publicado: (2017)

Estimands: bringing clarity and focus to research questions in clinical trials
por: Clark, Timothy Peter, et al.
Publicado: (2022)

Principles and recommendations for incorporating estimands into clinical study protocol templates
por: Lynggaard, Helle, et al.
Publicado: (2022)

Translating questions to estimands in randomized clinical trials with intercurrent events
por: Stensrud, Mats J., et al.
Publicado: (2022)

Estimands in published protocols of randomised trials: urgent improvement needed
por: Kahan, Brennan C., et al.
Publicado: (2021)

Why estimands are needed to define treatment effects in clinical trials
por: Keene, Oliver N., et al.
Publicado: (2023)

Optimizing Trial Designs for Targeted Therapies
por: Ondra, Thomas, et al.
Publicado: (2016)

Functional Loss and Mortality in Randomized Clinical Trials for Amyotrophic Lateral Sclerosis: To Combine, or Not to Combine—That is the Estimand
por: van Eijk, Ruben P.A., et al.
Publicado: (2022)

A narrative review of estimands in drug development and regulatory evaluation: old wine in new barrels?
por: Mitroiu, M., et al.
Publicado: (2020)

On estimands and the analysis of adverse events in the presence of varying follow‐up times within the benefit assessment of therapies
por: Unkel, Steffen, et al.
Publicado: (2018)

Marking 2-Years of New Thinking in Clinical Trials: The Estimand Journey
por: Fletcher, C., et al.
Publicado: (2022)

Re-randomisation trials in multi-episode settings: Estimands and independence estimators
por: Kahan, Brennan C, et al.
Publicado: (2022)

Estimands in cluster-randomized trials: choosing analyses that answer the right question
por: Kahan, Brennan C, et al.
Publicado: (2022)

Phase III Clinical Trials in First-Line Follicular Lymphoma: A Review of Their Design and Interpretation
por: Bachy, Emmanuel, et al.
Publicado: (2021)

Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example
por: Aroda, Vanita R., et al.
Publicado: (2019)

Evaluating how clear the questions being investigated in randomised trials are: systematic review of estimands
por: Cro, Suzie, et al.
Publicado: (2022)

Hypothetical Estimands in Clinical Trials: A Unification of Causal Inference and Missing Data Methods
por: Olarte Parra, Camila, et al.
Publicado: (2022)

Beyond “Intent‐to‐treat” and “Per protocol”: Improving assessment of treatment effects in clinical trials through the specification of an estimand
por: Pétavy, Frank, et al.
Publicado: (2020)

Commentary: Estimands in cluster trials: thinking carefully about the target of inferenceand the consequences for analysis choice
por: Hemming, Karla, et al.
Publicado: (2022)

Quantitative approaches underpinning decision making
por: Posch, Martin, et al.
Publicado: (2019)

Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data
por: Wharton, Sean, et al.
Publicado: (2021)

Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency
por: Collignon, Olivier, et al.
Publicado: (2018)

Estimation of treatment effects in short‐term depression studies. An evaluation based on the ICH E9(R1) estimands framework
por: Mitroiu, Marian, et al.
Publicado: (2022)

Treatment estimands in clinical trials of patients hospitalised for COVID-19: ensuring trials ask the right questions
por: Kahan, Brennan C., et al.
Publicado: (2020)

Statistical methods and graphical displays of quality of life with survival outcomes in oncology clinical trials for supporting the estimand framework
por: Sakamaki, Kentaro, et al.
Publicado: (2022)

Defining Clinical Trial Estimands: A Practical Guide for Study Teams with Examples Based on a Psychiatric Disorder
por: Polverejan, Elena, et al.
Publicado: (2023)

Starting a conversation about estimands with public partners involved in clinical trials: a co-developed tool
por: Cro, Suzie, et al.
Publicado: (2023)

Estimands for clinical endpoints in Tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial
por: Weir, Isabelle R, et al.
Publicado: (2023)

Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study
por: Rehal, Sunita, et al.
Publicado: (2023)

Adaptive designs based on the truncated product method
por: Neuhäuser, Markus, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_bf4mct8p619cuiveci4jq8g9ap